Huge support for our procedure from not just the entire industry but congressional offices as well. This should go a long way to actually gaining even more favourable reimbursement down the track as well as greater coverage by private insurers. MIGS is rapidly becoming a gold standard therapy for glaucoma and iTrack Advance is clearly one of the top devices.
Ann: Response to ASX Aware Query, page-6
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.0¢ |
Change
-0.005(1.89%) |
Mkt cap ! $59.49M | |||
| Open | High | Low | Value | Volume |
| 26.0¢ | 26.5¢ | 26.0¢ | $27.25K | 104.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 186581 | 25.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 18385 | 3 |
View Market Depth
| Last trade - 14.57pm 18/07/2024 (20 minute delay) ? |
| EYE (ASX) Chart |